Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Support | Patient+ | Guidelines | Weblinks | News | Products | Other
Print options:   Other options:   Bookmark and Share

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical, however some people find that they add depth to the patient information leaflets. You may find the abbreviations record helpful.

Infective Endocarditis

Post your experience
See others (2 there)

Infective endocarditis (IE) is an infection of the endocardium of the heart.

IE produces both intracardiac effects, e.g. valvular insufficiency and a wide variety of systemic effects, both from emboli (sterile and infected) and a variety of immunological mechanisms.

It is a disease that is easily overlooked or misdiagnosed and clinicians should be vigilant and well versed in the manifestations of IE to avoid missing the diagnosis.

Epidemiology

The incidence of infective endocarditis is approximately 1.7-6.2 cases per 100,000 patient years, although rates are higher in at-risk cohorts such as intravenous drug users.1 Incidence has remained constant for 50 years despite changes in the factors affecting incidence.2

Figures for incidence are similar between countries. It is 3 times more common in men and increasing in elderly patients (25-50% of cases occur in the over 60s) often associated with other disease, e.g. diabetes, cancer, alcoholism.

Risk factors

Pathogenesis

All cases have a nonbacterial thrombotic endocarditis (a sterile fibrin-platelet vegetation) as the prerequisite for adhesion and invasion. The site of this thrombus is influenced by the Venturi effect, with deposition of thrombus on the low pressure side.
There are differences in the different clinical situations:

  • Acute IE:
    The thrombus may be produced either by the invading organism or by valvular trauma (pacing wires, catheters, etc.).
  • Subacute IE:
    Sufficient inoculum of bacteria required to allow invasion of the thrombus, bacteria clumping with production of agglutinating antibodies.
  • Nonbacterial thrombotic endocarditis:
    This can result from, for example, renal failure, neoplasia, systemic lupus erythematosus (SLE) or malnutrition.

The valves most commonly affected by infective endocarditis are (in decreasing order of frequency):

Note: mechanical and bioprosthetic valves are affected equally.

The organisms responsible for infective endocarditis

  • Staphylococcus aureus:
    The most common cause of IE overall (acute and subacute); most common with prosthetic valves, acute IE, and IE related to intravenous drug abuse. High mortality rate.
    Coagulase negative S. aureus: causes subacute disease similar to Streptococcus viridans. Accounts for 30% of IE associated with prosthetic valves.
  • Streptococci:
    • S. viridans:
      50-60% of subacute IE cases.
    • Group D streptococci:
      Usually subacute and the third most common cause of IE.
    • Streptococcus intermedius:
      Acute and subacute infection. Causes 15% of all cases of IE.
    • Group A, C and G streptococci:
      Acute IE is similar to that with S. aureus. High mortality (up to 70%).
    • Group B streptococci:
      Acute disease, high mortality often requiring valve replacement. Occurs in pregnancy and the elderly particularly.
  • Pseudomonas aeruginosa:
    Usually acute IE and requires surgery for cure.
  • HACEK organisms (Haemophilus aphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae):
    Usually subacute disease and about 5% of all IE.
  • Fungi:
    Cause subacute disease.
  • Enterococci.

Presentation
  • Early disease subtle and nonspecific
  • Indolent process which may include:
    • Fatigue
    • Low-grade fever
    • Flu-like illness
    • Polymyalgia-like symptoms
    • Loss of appetite
    • Back pain
    • Pleuritic pain
    • Abdominal symptoms (may be pain, vomiting and appendicitis-like symptoms)
    • Symptoms akin to rheumatic fever
    • Weight loss
  • Cerebrovascular accident - less common
  • Congestive cardiac failure - less common
  • May be history of:
    • Invasive procedures (see above)
    • Recreational drug use
    • Dental disease
    • Gingivitis - most cases caused by transient bacteraemia from this
    • Symptoms usually arise 2 weeks after invasive procedures but diagnosed after 6 weeks
    • Fewer than half of patients have previously-diagnosed valvular disease
  • Developing disease produces a myriad of further clinical features of embolic or immunological origin when treatment/diagnosis delayed for weeks/months:
    • Acute meningitis - signs and symptoms but with sterile CSF
    • Hemiplegia from emboli in the middle cerebral artery (50% of patients may be first manifestation; has high mortality)
    • Renal infarcts causing painless haematuria
    • Splenic infarction causing pain
    • Blindness from retinal artery occlusion
    • Myocardial infarction from emboli in the coronary artery
    • Pulmonary emboli
    • Interstitial nephritis or proliferative glomerulonephritis from deposition of circulating immune complexes
    • Renal failure may result
    • Musculoskeletal symptoms (nearly half of patients) often from immunologically mediated synovitis
    • Immune-mediated vasculitis (causing Osler's nodes and Roth's spots)
    • Palpitations from immune-mediated myocarditis
    • Back pain (15% of patients) may have origin in immune complex deposition in disc spaces

Examination

  • Fever: elderly, chronically ill patients with subacute IE may not have fever, but the majority do
  • Heart murmurs:
    • Most patients have a murmur
    • Exception is right-sided IE where one third have murmurs
    • Only 15% have the classic 'changing murmur'
    • Most common murmur is aortic regurgitation
  • Petechiae:
    • Conjunctivae
    • Hands and feet (dorsum)
    • Chest and abdominal wall
    • Oral mucosae and soft palate
  • Splinter or subungual haemorrhages: Linear and red
  • Osler's nodes: small tender red-to-purple nodules pulp of terminal phalanges fingers and toes
  • Clubbing: only 10% of cases and usually in longstanding subacute IE
  • Roth's spots: retinal haemorrhages with pale centres
  • Janeway's lesions: irregular painless erythematous macules on the thenar and hypothenar eminence (usually with acute IE and S. aureus)
  • Arthritis:
    • With subacute IE usually asymmetric and up to 3 joints affected (fluid sterile)
    • Acute IE can give acute septic monoarticular arthritis
  • Splenomegaly: most often observed in longstanding subacute disease and often persists after treatment
  • Meningism/meningitis: purulent disease occurs in acute IE and aseptic variety in subacute IE
Differential diagnosis

The differential diagnosis could include all those conditions which occur as a complication or with progression of the disease.

Some of the more unusual diseases which may also have similar complex and varied manifestations are:

Investigations

Blood cultures

  • Blood cultures are used to demonstrate bacteraemia of 30 minutes or more duration
  • Draw 3 to 5 sets of blood cultures over 24 hours
  • In acute IE, 3 sets drawn from different venepuncture sites over 30 minutes demonstrates continuous bacteraemia
  • If cultures are negative 24 hours after stopping antibiotics, repeat after 7 days and, if still negative, reconsider IE diagnosis
  • Blood should not be drawn from IV lines (unless diagnosing line infection when simultaneous line and peripheral vein sampling may be used)
  • Prior use of antibiotics commonly gives false negative results
  • Probably 50% of culture results are estimated to be falsely positive
  • Fastidious organisms may require special culture media or prolonged incubation
  • HACEK organisms may require 3 weeks of culture and brucella organisms up to 6 weeks

Serological tests

These may be necessary to detect some organisms, e.g. legionella, chlamydia, brucella and coxiella species.

Imaging studies

Echocardiography is the indirect investigative method of choice. Note in general terms that:

  • Echocardiography is particularly useful in the elderly
  • Echocardiography is especially of use when clinical picture of IE but negative cultures
  • Echocardiography is useful to predict complications such as embolisation:
    • Larger vegetations (>10 mm diameter)
    • Multiple vegetations
    • Pedunculated vegetations
    • Prolapsing vegetations
  • Diagnosis of IE can never be excluded with negative echocardiogram (of whatever type)
  • Echocardiography should not be used to screen for IE because of high (15% plus) false positive rate (caused by thickened valves, etc.)

Transthoracic echocardiography (TTE):

  • TTE is the initial technique of choice for investigating infective endocarditis.1
  • Can detect vegetations in 60% of native valve endocarditis but much less often in prosthetic valves
  • TTE is good enough for most cases of IE

Transoesophageal echocardiography (TEE):

  • In high risk groups, TEE, with its higher sensitivity and specificity, may be needed if the TTE is normal and suspicion of infective endocarditis remains high1
  • Was developed to visualise prosthetic valves and right-sided pathology
  • It detects over 90% of all vegetations
  • TEE is better at detecting myocardial abscesses and vegetations on pacemaker leads

Two dimensional cardiac ultrasound Doppler studies have been a helpful advance providing more information on vegetations:

  • This may help in diagnosis but also in predicting risk of embolisation
  • Useful for visualising jet lesions and cusp perforation

Radionucleotide studies are of little value except for detecting splenic abscesses which are refractory to antibiotic treatment.
Electrocardiogram is useful to detect the 10% of patients who will develop conduction defects.

Diagnostic criteria

The Duke criteria - for definitive clinical diagnosis requires either 2 major or 1 major and 3 minor or 5 minor criteria from the list below:3

  • Major blood culture criteria:
    • 2 positive blood cultures for typical IE organisms
    • Persistently positive cultures for such organisms drawn >12 hours apart
    • 3 or more positive cultures drawn at least 1 hour apart
  • Major echocardiographic criteria:
    • Positive result and no alternative explanation
    • Myocardial abscess
    • Partial dehiscence of prosthetic valve
    • New valvular regurgitation
  • Positive molecular assays for specific gene targets
  • Positive serology for Coxiella burnetii, Bartonella spp., or Chlamydophila psittaci
  • Minor criteria:
    • Predisposing cardiac condition
    • Intravenous drug use
    • Fever (38°C or over)
    • Elevated C-reactive protein or erythrocyte sedimentation rate
    • Vascular lesions
    • Immunological phenomenon
    • Positive cultures less than 'major'
    • Positive echocardiographic results but insufficient for major criteria
  • Definitive pathological diagnosis from tissue

Management

Have a high index of suspicion:

  • Admit the patient to hospital for full investigation:
    • Blood cultures
    • Temperature records
    • Basic haematology and biochemistry investigations
    • ECG and CXR
    • Comprehensive TTE
  • Blood cultures:
    • With a sick patient (acute IE) take 3 sets of cultures at >1 hour intervals.
    • Less obvious IE (sub-acute presentation) requires 6 sets of cultures over 24-48 hours.
    • Cultures negative for the commoner organisms should be checked for unusual slow-growing organisms and fungi.
  • Referral:
    • When blood cultures are positive to a cardiologist.
    • At the outset to a microbiologist.
  • TTE or TEE:
    • If TTE difficult or suboptimal.
    • In order further to assess vegetations, abscesses or valvular perforations.
    • In all patients with prosthetic valve endocarditis (PVE).
  • Serological testing:
    • If the diagnosis is still suspected but cultures negative after 7 days.
    • Tests for Coxiella burnetii, Bartonella spp. and chlamydial organisms are available and should be performed.
  • Testing of biopsied tissue with special techniques to identify bacteria and fungi are being developed.
Antimicrobial therapy

Guidelines have been produced for treating IE.4,5,6

Treatment of infective endocarditis: guidelines from the RCP.

Type or variety of IE/ organism Antibiotic Dose/route Duration of treatment
IE due to penicillin-sensitive viridans streptococci and S. bovis
(MIC*<0.1 mg/l) in adults
Benzylpenicillin and gentamicin (b) Benylpenicillin: 7.2-12 g iv/24 hours in 4-6 divided doses
Gentamicin: 3-5 mg/kg iv daily in 2-3 divided doses (max 240 mg/day)
4-6 weeks (a)

2 weeks

As above but allergic to penicillin Vancomycin and gentamicin (b) Vancomycin: 30 mg/kg iv in 24 hours infused in 2 divided doses over 2 hours
Gentamicin: as above
4 weeks

2 weeks

IE due to penicillin-relative resistant viridans streptococci and S. bovis
(MIC*>0.1 mg/l) in adults
Benzylpenicillin and gentamicin (b) Benzylpenicillin: 12-14 g iv/24 hours in 4-6 divided doses
Gentamicin as above
4-6 weeks (a)

2 weeks(a)

As above but allergic to penicillin Vancomycin and gentamicin (b) Vancomycin and gentamicin as above Vancomycin and gentamicin as above
IE due to staphylococci on native valve:
penicillin-sensitive
(non-beta-lactamase producers)
Benzylpenicillin and gentamicin (b) Benzylpenicillin: 12-14 g regime as above.
Gentamicin as above
6 weeks benzylpenicillin
3-5 days of gentamicin only
IE due to staphylococci on native valve:
methicillin-sensitive staphylococci
(beta-lactamase producer)
Flucloxacillin and gentamicin (b) Flucloxacillin: 8-12 g iv/24 hours in 4 divided doses
Gentamicin as above
6 weeks flucloxacillin
3-5 days of gentamicin only
IE due to staphylococci on native valve:
methicillin-resistant staphylococci
(c)
Vancomycin (d) and gentamicin (b) Vancomycin: 30 mg/kg iv in 24 hours in 2 divided doses (infused over 2 hours)
Gentamicin as above
6 weeks vancomycin
3-5 days of gentamicin only
As above but allergic to penicillin Vancomycin (d) and gentamicin (b) As above for V and G As above for V and G
IE due to enterococci in adults:
gentamicin-sensitive or low level resistant organism (MIC*<500 mg/l)
Benzylpenicillin or ampicillin or amoxicillin and gentamicin (f), (b) Benzylpenicillin: 10-12 g iv/24 hours in 4-6 divided doses
Amp/amox: 12 g iv/24 hours in 4-6 divided doses
Gentamicin as above
All 4-6 weeks with 6 weeks if symptoms for more than 3 months of amox and amp (e)
As above but allergic to penicillin Vancomycin (d) and gentamicin (b) As above for V and G As above for V and G
(a) Adjust duration according to response and microbiologist advice.
(b) Check gentamicin levels regularly.
(c) Linezolid or Synercid® may be used with MRSA.
(d) Monitor peak and trough levels with advice.
(e) 6 weeks for symptoms over 3 months.
(f) Strains highly resistant to gentamicin seek microbiology advice. *MIC = minimum inhibitory concentration.
Surgical care

Surgery is needed in approximately 50% of patients who develop infective endocarditis and careful timing is essential to ensure a good outcome:1

  • In most stable patients surgery is best delayed until antibiotics are completed to reduce the risk of perioperative complications and early prosthetic valve endocarditis.
  • Unstable patients with haemodynamic or perivalvular complications have a poor prognosis and are best transferred to a specialist centre at the earliest opportunity.
Complications

These are an inherent part of the progression of the disease. Patients should be monitored for:

  • Valve dysfunction
  • Myocardial abscesses
  • Embolic phenomena
  • Heart failure
  • Metastatic infection
  • Immunological disease and organ dysfunction
  • Complications even after bacteriological cure
  • Conduction defects (patients with IE should have daily ECGs)
Prognosis

This varies markedly according to a variety of factors. The following outlines the range of prognosis when managed appropriately:

  • Native valve endocarditis:
    • S. viridans 98% cure rate
    • S. aureus 60-90% cure rate with worse results in occurring in those NOT abusing intravenous drugs
    • Fungal infections - cure rate less than 50%
  • PVE:
    • Cure rates at least 10% lower than above for each variety
    • Surgery needed more often
Prevention

See Prevention of Endocarditis record for details.


Document references
  1. Beynon RP, Bahl VK, Prendergast BD. Infective endocarditis. BMJ. August 2006.
  2. Hoen B; Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart. 2006 Nov;92(11):1694-700.
  3. Baddour LM, Wilson WR, Bayer AS, et al; Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005 Jun 14;111(23):e394-434. [abstract]
  4. Brusch JL; Infective Endocarditis, eMedicine 2007.
  5. Prophylaxis and treatment of infective endocarditis in adults : concise guidelines, Royal College of Physicians (2004)
  6. Elliott TS, Foweraker J, Gould FK, et al; Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2004 Dec;54(6):971-81. Epub 2004 Nov 16. [abstract]

Internet and further reading
  • Prophylaxis against infective endocarditis, NICE Clinical Guideline (March 2008); Antimicrobial prophylaxis against infective endocarditis
  • Harrison JL, Hoen B, Prendergast BD; Antibiotic prophylaxis for infective endocarditis. Lancet. 2008 Apr 19;371(9621):1317-9.
  • Connaughton M; Commentary: Controversies in NICE guidance on infective endocarditis. BMJ. 2008 Apr 5;336(7647):771.
  • Herring N, Sprigings DC; NICE on infective endocarditis: A call for national monitoring of antibiotic prophylaxis. BMJ. 2008 May 3;336(7651):976.
  • Guidelines on the management of valvular heart disease European Society of Cardiology European Heart Journal 2007;28:230-268
  • Wilson W, Taubert KA, Gewitz M, et al; Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Oct 9;116(15):1736-54. Epub 2007 Apr 19. [abstract]
Acknowledgements EMIS is grateful to Dr Hayley Willacy for writing this article and to Dr Richard Draper for earlier versions. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 1698
Document Version: 23
Document Reference: bgp580
Last Updated: 11 Sep 2009
Planned Review: 11 Sep 2011

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.

Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Support | Patient+ | Guidelines | Weblinks | News | Products | Other
Print options:   Other options:   Bookmark and Share
Want to search some more? Use the Google Search box below to search our site.

Related pages in Patient UK

Your Experience (^ top of page)

 Please add your experience about this condition / medicine
 View Patient Experience for 'Acute Infective Endocarditis' (2 there)
 Endocarditis - Infective

Support Group British Heart Foundation

 Antibiotic Prophylaxis
 Prevention of Endocarditis

 Guidelines on Infective Endocarditis
 Guidelines on Endocarditis

 Endocarditis
 Streptococcal Infections

Latest Health News

 View current health news

Medical equipment


Visit the Patient UK Medical Equipment shop

Books


Visit the Patient UK shop

Other - Useful resources (^ top of page)

Pictures, diagrams, photos, images, etc.
Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites

Want to search some more? Use the Google Search box below to search our site.

Advertisements













Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window